Gemcitabine in arterial injection chemotherapy for pancreatic cancer does not cause catheter obstruction or any other complication.
Ishikawa
Toru
T
Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp
Higuchi
Kazuo
K
Kubota
Tomoyuki
T
Seki
Kei-ichi
K
Honma
Terasu
T
Yoshida
Toshiaki
T
Kamimura
Tomoteru
T
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D057785:Catheters; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004867:Equipment Design; D006801:Humans; D007269:Injections, Intra-Arterial; D008422:Materials Testing; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013718:Tensile Strength; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine